Dowling & Yahnke’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $13.4M | Hold |
|
|||||
|
2022
Q2 | $11.2M | Hold |
|
|||||
|
2022
Q1 | $11.2M | Buy |
|
|||||
|
2021
Q4 | $9.2M | Sell |
|
|||||
|
2021
Q3 | $10.1M | Sell |
|
|||||
|
2021
Q2 | $12.1M | Sell |
|
|||||
|
2021
Q1 | $13.6M | Sell |
|
|||||
|
2020
Q4 | $26.9M | Sell |
|
|||||
|
2020
Q3 | $27.3M | Sell |
|
|||||
|
2020
Q2 | $39.8M | Hold |
|
|||||
|
2020
Q1 | $31.9M | Hold |
|
|||||
|
2019
Q4 | $40.8M | Hold |
|
|||||
|
2019
Q3 | $40.5M | Hold |
|
|||||
|
2019
Q2 | $43.4M | Hold |
|
|||||
|
2019
Q1 | $54.8M | Hold |
|
|||||
|
2018
Q4 | $39.4M | Hold |
|
|||||
|
2018
Q3 | $34.8M | Buy |
|
|||||
|
2018
Q2 | $28.1M | Sell |
|
|||||
|
2018
Q1 | $29.8M | Buy |
|
|||||
|
2017
Q4 | $34M | Hold |
|
|||||
|
2017
Q3 | $34.3M | Hold |
|
|||||
|
2017
Q2 | $34.4M | Buy |
|
|||||
|
2017
Q1 | $27.2M | Hold |
|
|||||
|
2016
Q4 | $32.3M | Sell |
|
|||||
|
2016
Q3 | $24.8M | Buy |
|
|||||
|
2016
Q2 | $15.8M | Sell |
|
|||||
|
2016
Q1 | $27.4M | Sell |
|
|||||
|
2015
Q4 | $41.9M | Hold |
|
|||||
|
2015
Q3 | $27.3M | Buy |
|
|||||
|
2015
Q2 | $38.9M | Buy |
|
|||||
|
2015
Q1 | $43.1M | Buy |
|
|||||
|
2014
Q4 | $41.8M | Buy |
|
|||||
|
2014
Q3 | $26.3M | Hold |
|
|||||
|
2014
Q2 | $23.3M | Hold |
|
|||||
|
2014
Q1 | $29.2M | Buy |
|
|||||
|
2013
Q4 | $26.9M | Hold |
|
|||||
|
2013
Q3 | $25.4M | Sell |
|
|||||
|
2013
Q2 | $20.8M | Buy |
|